With great pleasure, we accepted the kind invitation by the editors of The Cancer Journal to
coordinate a special issue on chronic lymphocytic leukemia (CLL). Our interest in CLL goes …

For decades, chronic lymphocytic leukemia (CLL) has been considered a somehow boring
indolent disease of the elderly without much need for therapeutic intervention and without …

Opinion statement Remarkable progress in elucidating the biology of chronic lymphocytic
leukemia (CLL) has been made over the last two decades. Improved understanding of CLL …

Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western
world and is due to the accumulation of mature B lymphocytes in the peripheral blood, bone …

Chronic lymphocytic leukemia (CLL) is a neoplastic disease characterized by the
accumulation of monoclonal lymphocytes in blood, bone marrow, and lymphoid tissues …

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world but
is rare in Asia. CLL has a highly varied clinical course. While advances in CLL therapy are …

Chronic lymphocytic leukaemia (CLL) is characterized by the relentless accumulation of
monoclonal CD5+ B lymphocytes in blood, bone marrow and lymphoid tissues. The disease …

Chronic lymphocytic leukaemia (CLL) is the most frequently diagnosed type of leukaemia in
the Western world. The majority of patients are> 65 years of age at diagnosis and the …

PURPOSE To review recent advances in the pathogenesis, biology, diagnosis, and
management of chronic lymphocytic leukemia (CLL). DESIGN A literature search restricted …

Chronic lymphocytic leukemia (CLL), is a typically slow-growing cancer which begins in
lymphocytes in the bone marrow and extends into the blood. It is the proliferation and …